Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov

International Journal of Antimicrobial Agents

Volumn 42, Issue 2, 2013, Pages 161-166

  Stockmann, Chris ^a,b,c   Sherwin, Catherine M T ^a   Ampofo, Krow ^a   Hersh, Adam L ^a   Pavia, Andrew T ^a   Byington, Carrie L ^a   Ward, Robert M ^a,b   Spigarelli, Michael G ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Anti infective agents; Antibacterial; Antibiotic; Antifungal; Antiviral

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT;

ARTICLE; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SAFETY; EVIDENCE BASED MEDICINE; FUNDING; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; INTERVENTION STUDY; OBSERVATIONAL STUDY; POLITICAL PARTICIPATION; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

ANTI-INFECTIVE AGENTS; ANTIBACTERIAL; ANTIBIOTIC; ANTIFUNGAL; ANTIVIRAL;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; COMMUNICABLE DISEASES; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; UNITED STATES; YOUNG ADULT;

EID: 84880294301     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.04.019     Document Type: Article

References (27)

1. P.M. Hawkey The growing burden of antimicrobial resistance J Antimicrob Chemother 62 Suppl. 1 2008 i1 i9
2. S. Foster The economic burden of antibiotic resistance - evidence from three recent studies 2010 Annual Conference on Antimicrobial Resistance 1-3 February 2010, Bethesda, MD 2010
3. B. Spellberg, R. Guidos, D. Gilbert, J. Bradley, H.W. Boucher, and W.M. Scheld The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America Clin Infect Dis 46 2008 155 164 (Pubitemid 351269151)
4. Interagency Task Force of Antimicrobial Resistance. 2009-2010 Progress towards implementation of: A public health action plan to combat antimicrobial resistance. http://www.cdc.gov/drugresistance/pdf/PReport-2009-2010-final- june2011.pdf [accessed 29.04.13].
5. H. Boucher, D. Gilbert, and D. Benjamin 10 × '20 progress: development of new drugs active against resistant Gram-negative bacilli 49th Annual Meeting of the Infectious Diseases Society of America 20-23 October 2011, Boston, MA 2011 [Abstract LB-27]
6. D.W. Kimberlin, and R.J. Whitley Antiviral resistance: mechanisms, clinical significance, and future implications J Antimicrob Chemother 37 1996 403 421 (Pubitemid 26116956)
7. J.A. DiMasi, L. Feldman, A. Seckler, and A. Wilson Trends in risks associated with new drug development: success rates for investigational drugs Clin Pharmacol Ther 87 2010 272 277
8. US Food and Drug Administration. Food and Drug Administration Modernization Act of 1997 (FDAMA): Public Law 105-15. http://www.fda.gov/ RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/ SignificantAmendmentstotheFDCAct/FDAMA/FullTextofFDAMAlaw/default.htm [accessed 17.08.12].
9. A.T. McCray, and N.C. Ide Design and implementation of a national clinical trials registry J Am Med Inform Assoc 7 2000 313 323 (Pubitemid 30314119)
10. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: publishing and editorial issues related to publication in biomedical journals: obligation to register clinical trials. http://www.icmje.org/publishing-10register.html [accessed 13.08.12].
11. US Food and Drug Administration. Food and Drug Administration Amendments Act of 2007: Public Law 110-85. http://www.gpo.gov/fdsys/pkg/PLAW-110publ85/pdf/ PLAW-110publ85.pdf [accessed 13.08.12].
12. D.A. Zarin, T. Tse, R.J. Williams, R.M. Califf, and N.C. Ide The ClinicalTrials.gov results database - update and key issues N Engl J Med 364 2011 852 860
13. US National Institutes of Health. About ClinicalTrails.gov. http://clinicaltrials.gov/ct2/info/about [accessed 16.08.12].
14. F.T. Bourgeois, S. Murthy, C. Pinto, K.L. Olson, J.P. Ioannidis, and K.D. Mandl Pediatric versus adult drug trials for conditions with high pediatric disease burden Pediatrics 130 2012 285 292
15. D. Moher CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials JAMA 279 1998 1489 1491 (Pubitemid 28228209)
16. R.M. Califf, D.A. Zarin, J.M. Kramer, R.E. Sherman, L.H. Aberle, and A. Tasneem Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010 JAMA 307 2012 1838 1847
17. US Food and Drug Administration Office of Device Evaluation. FDA summary of Safety and Effectiveness Data (SSED) Clinical Section Checklist. http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDRH/CDRHTransparency/ UCM220929.pdf. 2010 [accessed 17.08.12].
18. J.S. Ross, T. Tse, D.A. Zarin, H. Xu, L. Zhou, and H.M. Krumholz Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis BMJ 344 2012 d7292
19. H. Lee, D.S. Yim, H. Zhou, and C.C. Peck Evidence of effectiveness: how much can we extrapolate from existing studies? AAPS J 7 2005 E467 E474
20. R. Steinbrook Testing medications in children N Engl J Med 347 2002 1462 1470 (Pubitemid 35239728)
21. R.L. Smyth, and A.M. Weindling Research in children: ethical and scientific aspects Lancet 354 Suppl. 2 1999 SII21 SII24
22. C.M. Morel, and E. Mossialos Stoking the antibiotic pipeline BMJ 340 2010 c2115
23. F.T. Bourgeois, S. Murthy, and K.D. Mandl Outcome reporting among drug trials registered in ClinicalTrials.gov Ann Intern Med 153 2010 158 166
24. L. Bero, F. Oostvogel, P. Bacchetti, and K. Lee Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others PLoS Med 4 2007 e184
25. J. Lexchin, L.A. Bero, B. Djulbegovic, and O. Clark Pharmaceutical industry sponsorship and research outcome and quality: systematic review BMJ 326 2003 1167 1170 (Pubitemid 36649048)
26. D.A. Zarin, and T. Tse The effect of funding source on outcome reporting among drug trials Ann Intern Med 154 2011 137 138 author reply 138
27. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: publishing and editorial issues related to publication in biomedical journals: obligation to publish negative studies. http://www.icmje.org/publishing-1negative.html [accessed 17.08.12].